Richard and Susan Rogal recently committed $150,000,000 to the University of Michigan Comprehensive Cancer Center. It is the largest gift ever been made to Michigan Medicine. The money will be used to support promising cancer research and help train the next generation of researchers.
Read MoreTags: University of Michigan, new research funding, University Research, Michigan, University of Michigan Ann Arbor, MI, laboratory equipment suppliers, UMich, Midwest Region, research news, cancer research funding, cancer research grant, BioResearch Product Faire, cancer reserach, NIH awards 2017, 2017 research funding, University of Michigan research, university research funding
The University of Michigan Center for the Discovery of New Medicines (CDNM) has awarded research funding to seven faculty members from across the U-M campus for new drug development projects. The goal of University of Michigan’s CDNM is to accelerate the path toward commercialization for novel and translational approaches to potential therapies. They do this by assisting investigators with financial support as well as providing guidance and expertise. Pilot grants of up to $50,000 are awarded twice per year. They are chosen based on scientific strength, commercial opportunity and unmet medical need.
Read MoreTags: University of Michigan, new research funding, University Research, Michigan, University of Michigan Ann Arbor, MI, laboratory equipment suppliers, UMich, Midwest Region, research news, BioResearch Product Faire, NIH awards 2017, 2017 research funding, University of Michigan research, university research funding
The Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Childrens Hospital in Houston is a leading research institution continuously making breakthroughs in the field of neurological research on topics such as autism, Alzheimer's and epilepsy. Now, thanks to Charif Souki, co-founder of Tellurian, the NRI will have an additional $10 million to further their life science research. (Image courtesy of Zereshk via Wikimedia Commons)
Read MoreTags: new research funding, tmc, BioResearch Product Faire Event, Houston, TX, Neurological Disorder, Texas Childrens Hospital, Neurological Research
According to the National Science Foundation, The University of Michigan (UM) has ranked number one in total research spending among public universities in the United States for the past seven years. Just as impressive, the $1.48 billion spent in 2016/2017 represents a 6.4% increase over the previous finical year. Much of the university's funding came from federal grants.
Read MoreTags: University of Michigan, new research funding, New research facilities, University Research, Michigan, University of Michigan Ann Arbor, MI, laboratory equipment suppliers, UMich, Midwest Region, research news, BioResearch Product Faire, NIH awards 2017, 2017 research funding, University of Michigan research, university research funding
Of the four main types of Leukemia, Acute Myeloid Leukemia (AML) diagnoses make up nearly one-third of new leukemia cases and is most likely to occur in adults. Although common cancer treatment methods are used for AML patients, only about half go into remission after chemotherapy treatments. Factors such as age and overall health contribute to these remission rates. Researchers at top life science institutions around the world continually study AML to gain better understandings of the biology of this cancer that can lead to new and more effect treatment methods. (Image courtesy Wikimedia Commons)
Read MoreTags: CA, Leukemia, new research funding, cancer research, San Diego, SDVS, UCSD, Biotechnology Vendor Showcase, cancer research funding, 2018, AML Research, Acute Myeloid Leukemia
Tuberculosis (TB) is an infectious disease that affects nearly 1/3 of the world's population. Although eradication efforts have been undertaken, none have been successful and TB is still a leading cause around the world. Even though there are treatment methods for this infection, they are not always successful at killing the bacteria that cause TB. This provides life science researchers with more questions and research topics, to better understand the infection and bacteria and what causes treatments to work occasionally, but not always
Read MoreTags: tuberculosis, University of Massachusetts Amherst, new research funding, MA, NIH funding, Amherst, UMASS, 2018, TB Research
Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.
Read MoreTags: CA, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, 2017, cytomegalovirus
Lymphoma is one of the most common types of cancer, with Non-Hodgkin Lymphoma making up about 4% of all cancer cases in the United States, according to the American Cancer Society. Although treatment methods like chemotherapy and radiation therapy are able to treat the cancer, researchers still actively study this cancer to gain a better understanding of it to develop new targeted treatment methods.
Researchers from the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital have been studying new therapies for the cancer using T-cells, research that they will continue with the assistance of a new $11.5 million grant from the National Cancer Institute. (Image courtesy of TexasPathologistMSW ia Wikimedia Commons)
Read MoreTags: new research funding, cancer research, Texas Medical Center, tmc, Houston, TX, NIH funding, 2018, Lymphoma, Baylor College of Medicine
Valley Fever affects nearly 10,000 people in the United States each year, predominately in the Southwestern states of Arizona and California. This infection, caused by the fungus Coccidioide, affects different people in different ways: some get very ill while others are only mildly affected. However people are affected, there is no vaccine to cure the infection. A team of researchers from the University of Arizona, Tucson recently received a $4.8 million grant from the National Institute of Allergy and Infectious Disease (NIAID) to develop a vaccine for Valley Fever.
Read MoreTags: new research funding, AZ, UAZ, BioResearch Product Faire Event, Tucson, NIH funding, University of Arizona Tucson, 2017, Valley Fever
Tags: new research funding, AZ, UAZ, BioResearch Product Faire Event, Tucson, University of Arizona Tucson, 2017, macular degeneration
